RBA Wealth Management LLC Has $2.13 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

RBA Wealth Management LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.6% during the fourth quarter, Holdings Channel.com reports. The firm owned 4,208 shares of the healthcare conglomerate’s stock after selling 776 shares during the period. RBA Wealth Management LLC’s holdings in UnitedHealth Group were worth $2,129,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the business. Kathleen S. Wright Associates Inc. bought a new position in UnitedHealth Group in the 3rd quarter valued at $27,000. West Financial Advisors LLC bought a new position in UnitedHealth Group in the third quarter worth about $32,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $30,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $37,000. Finally, Quarry LP boosted its holdings in UnitedHealth Group by 132.1% in the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 37 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the topic of several recent analyst reports. Oppenheimer raised their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. KeyCorp reaffirmed an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Bank of America lowered their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, UBS Group reduced their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Trading Up 1.1 %

NYSE:UNH opened at $548.65 on Tuesday. The company has a market cap of $504.91 billion, a P/E ratio of 35.40, a P/E/G ratio of 1.48 and a beta of 0.61. The stock’s fifty day moving average price is $536.17 and its two-hundred day moving average price is $565.20. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the previous year, the business earned $5.83 earnings per share. The company’s quarterly revenue was up 6.8% on a year-over-year basis. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.63 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.53%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.